Tags:ChemicalChemicalsCommerceDevelopmentFacilityManufacturingMarketPlatformProductTechnology
BioAmber is a next-generation chemicals company with a focus on bio-sourced intermediates and particularly succinic acid. The company’s proprietary technology platform combines an exceptional know-how in fermentation, an innovative purification process and chemical catalysis to convert renewable feedstocks into chemicals that are cost-competitive replacements for petroleum-derived chemicals. BioAmber currently sells its first product, bio-succinic acid, to customers in a variety of chemical markets in connection with its product and market development efforts. BioAmber manufactures its bio-succinic acid in a facility using a commercial scale 350,000 liter fermenter in Pomacle, France, which the company believes to be one of the largest bio-based chemical manufacturing facilities in the world.
Total raised: $93.616583M

Investors 2

Funding Rounds 3

DateSeriesAmountInvestorsDeal News
24.06.2014-$18.616583...-agfunderne...
22.02.2012Series C$30M-finsmes.co...
04.05.2011Series B$45M-finsmes.co...

Mentions in press and media 8

DateTitleDescriptionCategoryAuthorSource
18.04.2017Why Securi...Paris-based venture capital fi...--agfunderne...
19.05.2016Avrio Capi...Avrio Capital has invested in ...--agfunderne...
09.02.2016Avrio Capi...Avrio Capital, the Canadian ag...--agfunderne...
25.08.2014July Round...We are excited to announce tha...--agfunderne...
24.06.2014BioAmber I...Canadian chemicals are raking ...--agfunderne...
22.02.2012BioAmber C...BioAmber Inc., a Plymouth, Min...funding U...-finsmes.co...
22.02.2012BioAmber C... MINNEAPOLIS, MN, Next genera...--vcnewsdail...
04.05.2011BioAmber R...BioAmber Inc., a Minneapolis, ...funding U...-finsmes.co...